Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Randomised Trial of First Line Treatment Pathways for Newly Diagnosed Immune Thrombocytopenia: Standard Steroid Treatment Versus Combined Steroid and Mycophenolate

NCT03156452 is registered in ClinicalTrials.gov with University Hospitals Bristol and Weston NHS Foundation Trust as lead sponsor.

NCT NCT03156452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03156452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Randomised Trial of First Line Treatment Pathways for Newly Diagnosed Immune Thrombocytopenia: Standard Steroid Treatment Versus Combined Steroid and Mycophenolate
Lead sponsor
University Hospitals Bristol and Weston NHS Foundation Trust
Phase
Phase 3
Overall status
Completed
Start date
October 25, 2017
Completion date
March 5, 2020
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenia